CD34 and age-related macular degeneration: As a proof of concept, we hypothesized that ARCA can be used to identify and enumerate EPCs, defined as CD34+VEGFR2+CD45– peripheral blood mononuclear cells, in patients with ARMD similar to previous studies using FACS and peripheral blood mononuclear cell cultures.